EC90 of ropivacaine for dural puncture epidural analgesia for labor

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042111

Enrollment

Unknown

Registered

2021-01-14

Start date

2021-01-14

Completion date

Unknown

Last updated

2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor analgesia

Interventions

experimental group:ropivacaine

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: (1) ASA I-II Pregnant women who are at 37-42 weeks of gestation and willing to undergo labor analgesia; (2) Weight 50-100kg, height 150-170cm; (3) Cervical dilatation = 5 when receiving epidural analgesia.

Exclusion criteria

Exclusion criteria: (1) Age 35 years old; (2) Hypertensive disorder complicating pregnancy, gestational diabetes mellitus or eclampsia; (3) The parturient has the history of uterine operation, uterine malformation or abnormality, placenta previa and other parturients who are not suitable for vaginal delivery; (4) Contraindications of intraspinal anesthesia exist in parturients.

Design outcomes

Primary

Measure	Time frame
pain visual analogue scale;	—

Countries

China

Contacts

Public ContactChen Jiawei

Obstetrics and Gynecology Hospital of Fudan University

982777383@qq.com+86 13166191994

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026